You just read:

AMO Pharma Announces Initiation of Clinical Trial conducted by Mount Sinai to Study AMO-01 in Treatment of Phelan-McDermid Syndrome

News provided by

AMO Pharma Limited

May 07, 2018, 11:26 ET